Cargando…

Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19

Detalles Bibliográficos
Autores principales:	Bakry, Nourhan Saied, Abdelgawad, Mai, Abdel-Latif, Ahmed, Lotfy, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482358/ https://www.ncbi.nlm.nih.gov/pubmed/34591281 http://dx.doi.org/10.1007/s13577-021-00620-1

Ejemplares similares

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
por: Abdelgawad, Mai, et al.
Publicado: (2021)

Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
por: Lotfy, Ahmed, et al.
Publicado: (2023)

Anti-VCAM 1 Antibody-Coated Mesenchymal Stromal Cells Attenuate Experimental Colitis via Immunomodulation
por: Chen, Qianqian, et al.
Publicado: (2019)

EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer
por: Hassanein, Sarah Sayed, et al.
Publicado: (2021)

Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells
por: Generali, Melanie, et al.
Publicado: (2021)

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases
por: Bank, Sarbashri, et al.
Publicado: (2021)

Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients
por: Ohuchi, Kentaro, et al.
Publicado: (2021)

Green nanocoating-based polysaccharides decorated with ZnONPs doped Egyptian kaolinite for antimicrobial coating paper
por: Hasanin, Mohamed S., et al.
Publicado: (2023)

Ag-CuO/epoxy hybrid nanocomposites as anti-corrosive coating and self-cleaning on copper substrate
por: Abdel-karim, Amal M., et al.
Publicado: (2023)

Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review
por: Ahmed, Sara M., et al.
Publicado: (2018)

Editorial: Multipotent stromal cells and microenvironment of the tissue healing
por: Lotfy, Ahmed, et al.
Publicado: (2023)

ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas
por: De, Auley, et al.
Publicado: (2021)

Spectrophotometric Determination of Captopril and Penicillamine through the Use of Ligand Exchange Complexation Reactions
por: Belal, Saied, et al.
Publicado: (2011)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
por: Zhang, Fengwen, et al.
Publicado: (2023)

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014)

The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
por: Weiss, Daniel J., et al.
Publicado: (2019)

Understanding the impact of bioactive coating materials for human mesenchymal stromal cells and implications for manufacturing
por: Silva Couto, Pedro, et al.
Publicado: (2023)

Using Mesenchymal Stromal Cells in Islet Transplantation
por: Arzouni, Ahmed A., et al.
Publicado: (2018)

Anti-inflammatory and immune modulatory properties of mesenchymal stromal cells
por: Fibbe, Willem E
Publicado: (2011)

Mesenchymal stromal cells as regulators of anti-tumour immune response
por: Poggi, Alessandro, et al.
Publicado: (2015)

Anti-tubulin-alpha-1c antibody as a marker of value in Behçet syndrome
por: Amin, Mariam Maged, et al.
Publicado: (2022)

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection
por: Avanzini, Maria A., et al.
Publicado: (2021)

Xeno-Free Strategies for Safe Human Mesenchymal Stem/Stromal Cell Expansion: Supplements and Coatings
por: Cimino, M., et al.
Publicado: (2017)

Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study
por: Yuan, Mo, et al.
Publicado: (2017)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020)

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha NC, Nádia de Cássia, et al.
Publicado: (2019)

Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy
por: Mohammadalipour, Amina, et al.
Publicado: (2020)

Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19
por: Lu, Kun, et al.
Publicado: (2022)

Imaging of COVID-19 vasculopathy from head to toe: Egyptian collective experience after 2 years of the pandemic
por: Fathy, Ahmed, et al.
Publicado: (2022)

Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats
por: Ahmed, Osama M., et al.
Publicado: (2023)

Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
por: Samir, Ahmed, et al.
Publicado: (2020)

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
por: Sawalha, Amr H., et al.
Publicado: (2020)

Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients
por: Cui, Rongtao, et al.
Publicado: (2016)

Computational comparative analysis identifies potential stemness-related markers for mesenchymal stromal/stem cells
por: Ghabriel, Myret, et al.
Publicado: (2023)

Anti‐apoptotic effects of human gingival mesenchymal stromal cells on polymorphonuclear leucocytes
por: Blufstein, Alice, et al.
Publicado: (2021)

Compensatory Upregulation of Anti-Beta-Adrenergic Receptor Antibody Levels Might Prevent Heart Failure Presentation in Pediatric Myocarditis
por: Seidel, Franziska, et al.
Publicado: (2022)

Nongenetic surface engineering of mesenchymal stromal cells with polyvalent antibodies to enhance targeting efficiency
por: Ye, Tenghui, et al.
Publicado: (2023)

Partial loss of genes might open therapeutic window
por: Liu, Bo, et al.
Publicado: (2017)

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
por: Bank, J. R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6i8s49o935c5ndlfebkflle0ea